Raj Som Pruthi - Jul 24, 2024 Form 4 Insider Report for enGene Holdings Inc. (ENGN)

Role
Chief Medical Officer
Signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person
Stock symbol
ENGN
Transactions as of
Jul 24, 2024
Transactions value $
$0
Form type
4
Date filed
7/25/2024, 08:32 PM
Previous filing
Jul 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENGN Stock Option (Right to Buy) Award $0 +110K $0.00 110K Jul 24, 2024 Common Shares 110K $8.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests at 25% on July 24, 2025, which is the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years.